Copyright Reports & Markets. All rights reserved.

Global Acamprosate Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Request for Sample of this report
Buy now

Table of Contents

    1 Market Overview

    • 1.1 Acamprosate Introduction
    • 1.2 Market Analysis by Type
      • 1.2.1 333 mg Delayed Release Tablet
      • 1.2.2 Others
    • 1.3 Market Analysis by Applications
      • 1.3.1 Hospital
      • 1.3.2 Clinic
      • 1.3.3 Others
    • 1.4 Market Analysis by Regions
      • 1.4.1 North America (United States, Canada and Mexico)
        • 1.4.1.1 United States Market States and Outlook (2014-2024)
        • 1.4.1.2 Canada Market States and Outlook (2014-2024)
        • 1.4.1.3 Mexico Market States and Outlook (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
        • 1.4.2.1 Germany Market States and Outlook (2014-2024)
        • 1.4.2.2 France Market States and Outlook (2014-2024)
        • 1.4.2.3 UK Market States and Outlook (2014-2024)
        • 1.4.2.4 Russia Market States and Outlook (2014-2024)
        • 1.4.2.5 Italy Market States and Outlook (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
        • 1.4.3.1 China Market States and Outlook (2014-2024)
        • 1.4.3.2 Japan Market States and Outlook (2014-2024)
        • 1.4.3.3 Korea Market States and Outlook (2014-2024)
        • 1.4.3.4 India Market States and Outlook (2014-2024)
        • 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
      • 1.4.4 South America, Middle East and Africa
        • 1.4.4.1 Brazil Market States and Outlook (2014-2024)
        • 1.4.4.2 Egypt Market States and Outlook (2014-2024)
        • 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
        • 1.4.4.4 South Africa Market States and Outlook (2014-2024)
        • 1.4.4.5 Turkey Market States and Outlook (2014-2024)
    • 1.5 Market Dynamics
      • 1.5.1 Market Opportunities
      • 1.5.2 Market Risk
      • 1.5.3 Market Driving Force

    2 Manufacturers Profiles

    • 2.1 Merck Group
      • 2.1.1 Business Overview
      • 2.1.2 Acamprosate Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Merck Group Acamprosate Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 Teva
      • 2.2.1 Business Overview
      • 2.2.2 Acamprosate Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 Teva Acamprosate Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 Zydus Pharmaceuticals
      • 2.3.1 Business Overview
      • 2.3.2 Acamprosate Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 Zydus Pharmaceuticals Acamprosate Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 Mylan
      • 2.4.1 Business Overview
      • 2.4.2 Acamprosate Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 Mylan Acamprosate Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 Glenmark Pharmaceuticals
      • 2.5.1 Business Overview
      • 2.5.2 Acamprosate Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 Glenmark Pharmaceuticals Acamprosate Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Acamprosate Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

    • 3.1 Global Acamprosate Sales and Market Share by Manufacturer (2017-2018)
    • 3.2 Global Acamprosate Revenue and Market Share by Manufacturer (2017-2018)
    • 3.3 Market Concentration Rate
      • 3.3.1 Top 3 Acamprosate Manufacturer Market Share in 2018
      • 3.3.2 Top 6 Acamprosate Manufacturer Market Share in 2018
    • 3.4 Market Competition Trend

    4 Global Acamprosate Market Analysis by Regions

    • 4.1 Global Acamprosate Sales, Revenue and Market Share by Regions
      • 4.1.1 Global Acamprosate Sales and Market Share by Regions (2014-2019)
      • 4.1.2 Global Acamprosate Revenue and Market Share by Regions (2014-2019)
    • 4.2 North America Acamprosate Sales and Growth Rate (2014-2019)
    • 4.3 Europe Acamprosate Sales and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Acamprosate Sales and Growth Rate (2014-2019)
    • 4.5 South America Acamprosate Sales and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Acamprosate Sales and Growth Rate (2014-2019)

    5 North America Acamprosate by Country

    • 5.1 North America Acamprosate Sales, Revenue and Market Share by Country
      • 5.1.1 North America Acamprosate Sales and Market Share by Country (2014-2019)
      • 5.1.2 North America Acamprosate Revenue and Market Share by Country (2014-2019)
    • 5.2 United States Acamprosate Sales and Growth Rate (2014-2019)
    • 5.3 Canada Acamprosate Sales and Growth Rate (2014-2019)
    • 5.4 Mexico Acamprosate Sales and Growth Rate (2014-2019)

    6 Europe Acamprosate by Country

    • 6.1 Europe Acamprosate Sales, Revenue and Market Share by Country
      • 6.1.1 Europe Acamprosate Sales and Market Share by Country (2014-2019)
      • 6.1.2 Europe Acamprosate Revenue and Market Share by Country (2014-2019)
    • 6.2 Germany Acamprosate Sales and Growth Rate (2014-2019)
    • 6.3 UK Acamprosate Sales and Growth Rate (2014-2019)
    • 6.4 France Acamprosate Sales and Growth Rate (2014-2019)
    • 6.5 Russia Acamprosate Sales and Growth Rate (2014-2019)
    • 6.6 Italy Acamprosate Sales and Growth Rate (2014-2019)

    7 Asia-Pacific Acamprosate by Country

    • 7.1 Asia-Pacific Acamprosate Sales, Revenue and Market Share by Country
      • 7.1.1 Asia-Pacific Acamprosate Sales and Market Share by Country (2014-2019)
      • 7.1.2 Asia-Pacific Acamprosate Revenue and Market Share by Country (2014-2019)
    • 7.2 China Acamprosate Sales and Growth Rate (2014-2019)
    • 7.3 Japan Acamprosate Sales and Growth Rate (2014-2019)
    • 7.4 Korea Acamprosate Sales and Growth Rate (2014-2019)
    • 7.5 India Acamprosate Sales and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Acamprosate Sales and Growth Rate (2014-2019)

    8 South America Acamprosate by Country

    • 8.1 South America Acamprosate Sales, Revenue and Market Share by Country
      • 8.1.1 South America Acamprosate Sales and Market Share by Country (2014-2019)
      • 8.1.2 South America Acamprosate Revenue and Market Share by Country (2014-2019)
    • 8.2 Brazil Acamprosate Sales and Growth Rate (2014-2019)
    • 8.3 Argentina Acamprosate Sales and Growth Rate (2014-2019)
    • 8.4 Colombia Acamprosate Sales and Growth Rate (2014-2019)

    9 Middle East and Africa Acamprosate by Countries

    • 9.1 Middle East and Africa Acamprosate Sales, Revenue and Market Share by Country
      • 9.1.1 Middle East and Africa Acamprosate Sales and Market Share by Country (2014-2019)
      • 9.1.2 Middle East and Africa Acamprosate Revenue and Market Share by Country (2014-2019)
    • 9.2 Saudi Arabia Acamprosate Sales and Growth Rate (2014-2019)
    • 9.3 Turkey Acamprosate Sales and Growth Rate (2014-2019)
    • 9.4 Egypt Acamprosate Sales and Growth Rate (2014-2019)
    • 9.5 Nigeria Acamprosate Sales and Growth Rate (2014-2019)
    • 9.6 South Africa Acamprosate Sales and Growth Rate (2014-2019)

    10 Global Acamprosate Market Segment by Type

    • 10.1 Global Acamprosate Sales, Revenue and Market Share by Type (2014-2019)
      • 10.1.1 Global Acamprosate Sales and Market Share by Type (2014-2019)
      • 10.1.2 Global Acamprosate Revenue and Market Share by Type (2014-2019)
    • 10.2 333 mg Delayed Release Tablet Sales Growth and Price
      • 10.2.1 Global 333 mg Delayed Release Tablet Sales Growth (2014-2019)
      • 10.2.2 Global 333 mg Delayed Release Tablet Price (2014-2019)
    • 10.3 Others Sales Growth and Price
      • 10.3.1 Global Others Sales Growth (2014-2019)
      • 10.3.2 Global Others Price (2014-2019)

    11 Global Acamprosate Market Segment by Application

    • 11.1 Global Acamprosate Sales Market Share by Application (2014-2019)
    • 11.2 Hospital Sales Growth (2014-2019)
    • 11.3 Clinic Sales Growth (2014-2019)
    • 11.4 Others Sales Growth (2014-2019)

    12 Acamprosate Market Forecast (2019-2024)

    • 12.1 Global Acamprosate Sales, Revenue and Growth Rate (2019-2024)
    • 12.2 Acamprosate Market Forecast by Regions (2019-2024)
      • 12.2.1 North America Acamprosate Market Forecast (2019-2024)
      • 12.2.2 Europe Acamprosate Market Forecast (2019-2024)
      • 12.2.3 Asia-Pacific Acamprosate Market Forecast (2019-2024)
      • 12.2.4 South America Acamprosate Market Forecast (2019-2024)
      • 12.2.5 Middle East and Africa Acamprosate Market Forecast (2019-2024)
    • 12.3 Acamprosate Market Forecast by Type (2019-2024)
      • 12.3.1 Global Acamprosate Sales Forecast by Type (2019-2024)
      • 12.3.2 Global Acamprosate Market Share Forecast by Type (2019-2024)
    • 12.4 Acamprosate Market Forecast by Application (2019-2024)
      • 12.4.1 Global Acamprosate Sales Forecast by Application (2019-2024)
      • 12.4.2 Global Acamprosate Market Share Forecast by Application (2019-2024)

    13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
      • 13.1.1 Direct Marketing
      • 13.1.2 Indirect Marketing
      • 13.1.3 Marketing Channel Future Trend
    • 13.2 Distributors, Traders and Dealers

    14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology

      Description

      Scope of the Report:
      The worldwide market for Acamprosate is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
      This report focuses on the Acamprosate in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

      Market Segment by Manufacturers, this report covers
      Merck Group
      Teva
      Zydus Pharmaceuticals
      Mylan
      Glenmark Pharmaceuticals

      Market Segment by Regions, regional analysis covers
      North America (United States, Canada and Mexico)
      Europe (Germany, France, UK, Russia and Italy)
      Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
      South America (Brazil, Argentina, Colombia etc.)
      Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

      Market Segment by Type, covers
      333 mg Delayed Release Tablet
      Others

      Market Segment by Applications, can be divided into
      Hospital
      Clinic
      Others

      The content of the study subjects, includes a total of 15 chapters:
      Chapter 1, to describe Acamprosate product scope, market overview, market opportunities, market driving force and market risks.
      Chapter 2, to profile the top manufacturers of Acamprosate, with price, sales, revenue and global market share of Acamprosate in 2017 and 2018.
      Chapter 3, the Acamprosate competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
      Chapter 4, the Acamprosate breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
      Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
      Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
      Chapter 12, Acamprosate market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
      Chapter 13, 14 and 15, to describe Acamprosate sales channel, distributors, customers, research findings and conclusion, appendix and data source.
      Buy now